Have your own idea? Try our Stock Screener
Pakistani (KSE) Pharma Industry Analysis
UpdatedApr 18, 2025
DataAggregated Company Financials
Companies11
- 7D2.7%
- 3M-2.4%
- 1Y145.8%
- YTD-1.9%
In the last week, the Pharma industry is up 4.9%, with GlaxoSmithKline Pakistan up 9.5%. This takes the industry's 12 month performance to a gain of 142%. Looking forward, earnings are forecast to grow by 36% annually.
Industry Valuation and Performance
Has the Pakistani Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 18 Apr 2025 | PK₨492.0b | PK₨272.6b | PK₨23.2b | 22.2x | 21.2x | 1.8x |
| Sun, 16 Mar 2025 | PK₨470.8b | PK₨266.0b | PK₨20.9b | 25.5x | 22.6x | 1.8x |
| Tue, 11 Feb 2025 | PK₨494.6b | PK₨257.1b | PK₨19.2b | 24.2x | 25.8x | 1.9x |
| Thu, 09 Jan 2025 | PK₨462.2b | PK₨257.1b | PK₨19.2b | 22.4x | 24.1x | 1.8x |
| Sat, 07 Dec 2024 | PK₨460.9b | PK₨257.0b | PK₨19.0b | 22.4x | 24.2x | 1.8x |
| Mon, 04 Nov 2024 | PK₨343.3b | PK₨258.6b | PK₨19.3b | 16.3x | 17.7x | 1.3x |
| Wed, 02 Oct 2024 | PK₨278.5b | PK₨251.2b | PK₨12.3b | 17.1x | 22.6x | 1.1x |
| Fri, 30 Aug 2024 | PK₨261.9b | PK₨249.4b | PK₨12.0b | 17.6x | 21.9x | 1.1x |
| Sun, 28 Jul 2024 | PK₨238.9b | PK₨243.6b | PK₨8.3b | 16.6x | 28.9x | 1x |
| Tue, 25 Jun 2024 | PK₨240.0b | PK₨243.6b | PK₨8.3b | 16.1x | 29x | 1x |
| Thu, 23 May 2024 | PK₨225.9b | PK₨237.0b | PK₨7.6b | 21.2x | 29.5x | 1x |
| Sat, 20 Apr 2024 | PK₨184.5b | PK₨228.8b | PK₨6.6b | 34.8x | 28.1x | 0.8x |
| Mon, 18 Mar 2024 | PK₨167.6b | PK₨224.1b | PK₨6.3b | 20.8x | 26.5x | 0.7x |
| Wed, 14 Feb 2024 | PK₨157.9b | PK₨221.2b | PK₨6.3b | 19.5x | 25.1x | 0.7x |
| Fri, 12 Jan 2024 | PK₨168.6b | PK₨221.2b | PK₨6.3b | 20.4x | 26.8x | 0.8x |
| Sun, 10 Dec 2023 | PK₨179.8b | PK₨219.4b | PK₨6.2b | 23.5x | 29.2x | 0.8x |
| Tue, 07 Nov 2023 | PK₨150.8b | PK₨218.2b | PK₨6.2b | 19.9x | 24.3x | 0.7x |
| Thu, 05 Oct 2023 | PK₨122.7b | PK₨209.6b | PK₨6.5b | 15.3x | 19x | 0.6x |
| Sat, 02 Sep 2023 | PK₨122.0b | PK₨209.4b | PK₨8.4b | 12.1x | 14.6x | 0.6x |
| Mon, 31 Jul 2023 | PK₨140.4b | PK₨205.6b | PK₨8.7b | 12.8x | 16.1x | 0.7x |
| Wed, 28 Jun 2023 | PK₨127.2b | PK₨205.6b | PK₨8.7b | 12.2x | 14.6x | 0.6x |
| Fri, 26 May 2023 | PK₨137.5b | PK₨202.0b | PK₨11.0b | 13.1x | 12.5x | 0.7x |
| Sun, 23 Apr 2023 | PK₨137.1b | PK₨194.2b | PK₨13.8b | 9.4x | 9.9x | 0.7x |
| Tue, 21 Mar 2023 | PK₨144.3b | PK₨191.5b | PK₨15.1b | 9.6x | 9.6x | 0.8x |
| Thu, 16 Feb 2023 | PK₨146.7b | PK₨189.4b | PK₨15.2b | 9.7x | 9.6x | 0.8x |
| Sat, 14 Jan 2023 | PK₨148.5b | PK₨189.4b | PK₨15.2b | 9.6x | 9.7x | 0.8x |
| Mon, 12 Dec 2022 | PK₨169.5b | PK₨188.7b | PK₨15.0b | 11.3x | 11.3x | 0.9x |
| Wed, 09 Nov 2022 | PK₨188.7b | PK₨187.0b | PK₨15.5b | 12.4x | 12.2x | 1x |
| Fri, 07 Oct 2022 | PK₨197.9b | PK₨179.3b | PK₨18.4b | 10.5x | 10.7x | 1.1x |
| Sun, 04 Sep 2022 | PK₨205.3b | PK₨172.4b | PK₨18.5b | 11.9x | 11.1x | 1.2x |
| Tue, 02 Aug 2022 | PK₨204.9b | PK₨169.3b | PK₨21.5b | 10.2x | 9.5x | 1.2x |
| Thu, 30 Jun 2022 | PK₨211.9b | PK₨167.9b | PK₨21.4b | 10.7x | 9.9x | 1.3x |
| Sat, 28 May 2022 | PK₨205.2b | PK₨163.7b | PK₨21.2b | 9.2x | 9.7x | 1.3x |
| Mon, 25 Apr 2022 | PK₨221.8b | PK₨161.9b | PK₨21.1b | 10x | 10.5x | 1.4x |
Price to Earnings Ratio
10.5x
Current Industry PE
- Investors are optimistic on the Pakistani Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 21.0x which is higher than its 3-year average PE of 18.5x.
- The 3-year average PS ratio of 1.0x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 3.3% per year over the last three years.
- Revenues for these companies have grown 19% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare industry?
| PK Market | 0.14% | |
| Healthcare | 2.83% | |
| Pharma | 2.69% | |
| Pharma | 2.69% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan | PK₨455.87 | 9.5% +PK₨12.6b | 399.1% | PE22.2x | |
| HINOON Highnoon Laboratories | PK₨986.21 | 5.3% +PK₨2.6b | 85.0% | PE15.4x | |
| AGP AGP | PK₨198.00 | 2.8% +PK₨1.5b | 146.1% | PE20.8x | |
| BFBIO BF Biosciences | PK₨155.88 | 1.7% +PK₨235.0m | n/a | PE32.2x |